You must be a subscriber to see the full results of your search.
Please log in or subscribe below if you are not already a subscriber.
The Daily News subscribers get full access to more than
million names and addresses along with powerful search and download features.
Get the business leads you need with powerful searches of public records and notices.
Download listings into your spreadsheet or database.
Learn more about our services
| Search again
Editorial Results (free)
1. Merck Third-Quarter Net Income Falls on Charges, Lower Sales
- Tuesday, October 29, 2013
Merck & Co.'s third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges.
2. New Coupons Aim to Keep People Off Generic Drugs
- Tuesday, August 21, 2012
TRENTON, N.J. (AP) – If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.
3. Morgan Stanley Closes a Bleak Bank Earnings Season
- Friday, July 20, 2012
NEW YORK (AP) — It's tough being a big bank these days.
Morgan Stanley, the storied investment house, reported Thursday that its revenue was down sharply for April through June and its profit missed Wall Street expectations. Its stock was clobbered — down more than 5 percent.
4. Pfizer Q2 Net Up 5 Pct. on Lower Charges, Taxes
- Wednesday, August 03, 2011
Generic competition cut deeper into drugmaker Pfizer Inc.'s sales in the second quarter – with the U.S. patent expiration for its cholesterol fighter Lipitor, the world's top-selling drug, just five months away.
5. Schering-Plough Purchase Hikes Merck Sales, Profit
- Wednesday, February 17, 2010
TRENTON, N.J. (AP) – Drugmaker Merck & Co. on Tuesday posted huge jumps in revenue and profit for the fourth quarter, mainly because of its purchase of Schering-Plough Corp., whose consumer products division is based in Memphis.
6. Pfizer Posts Big Jump in Q4 Sales, Profit
- Thursday, February 04, 2010
TRENTON, N.J. (AP) - Drugmaker Pfizer Inc., well into integrating its new Wyeth unit, posted a 34 percent jump in revenue Wednesday, but $3.2 billion in acquisition and restructuring charges and higher costs across the board weighed down profit.
7. Tenn. Rep. Gordon Won't Seek Re-Election Next Year
- Tuesday, December 15, 2009
WASHINGTON (AP) - Rep. Bart Gordon, a 13-term congressman from Tennessee, announced Monday he will not seek re-election next year, the latest Democrat in a string of retirements.
Gordon, 60, won re-election easily last year, garnering 74 percent of the vote, but was still on a list of Democrats targeted by Republicans in midterm elections.
8. Drugmaker Wyeth Posts Flat 1st-Quarter Profit
- Thursday, April 30, 2009
TRENTON, N.J. (AP) - Drugmaker Wyeth, which is being acquired by drug giant Pfizer, on Wednesday posted a flat first-quarter profit but beat analysts' expectations, as cost cuts offset lower revenue, particularly for its top seller, blockbuster antidepressant Effexor.
9. Glaxo and Pfizer Create New HIV Drug Company
- Monday, April 20, 2009
TRENTON, N.J. (AP) - Pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. will pool resources to create a new company to develop and sell HIV medicines, leveraging a small investment into the No. 2 market position.
10. Pfizer to Buy Wyeth for $68B; Cut 8,000 Jobs
- Tuesday, January 27, 2009
TRENTON, N.J. (AP) - No. 1 drugmaker Pfizer Inc. said Monday it is buying No. 12 Wyeth for $68 billion in a deal that ultimately will wipe out nearly 20,000 jobs but quickly boost Pfizer's revenue and profit and transform it overnight into a medicine cabinet for all.
11. Bristol-Myers Triples 3Q Profit on Business Sale
- Friday, October 24, 2008
TRENTON, N.J. (AP) - Bristol-Myers Squibb Co. said Thursday its third-quarter profit tripled, mainly because of a big gain from selling its high-tech wound care business.